Home / Stocks / BALPHARMA
NSE · BALPHARMA

Bal Pharma Limited

Sector: — · ISIN: INE083D01012

₹88.24 -2.50% as of 13 Aug 2026
Market Cap
140.49 Cr
P/E Ratio
22.34
P/B Ratio
1.71
ROE
7.68%
ROCE
18.01%
Dividend Yield
—
52W High
₹93.79
52W Low
₹65.70

Quarterly financials

MetricQ1 2026-27Q4 2025-26
Revenue88.62 Cr84.08 Cr
Net Profit1.14 Cr3.60 Cr
EPS0.712.26
Operating Profit5.60 Cr7.27 Cr

Figures in Cr (crore) unless noted. Source: NSE XBRL filings.

Shareholding pattern

Promoter
50.86%
Public
49.14%
FII
—
DII
—

As of 30 Jun 2026.

Recent corporate actions

No corporate actions on record for this stock.

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs